Asia-Pacific Multicancer Screening Market Projected to Reach $1.40 Billion by 2032

News provided by

Dec 07, 2023, 11:00 ET

DUBLIN, Dec. 7, 2023 /PRNewswire/ -- The "Asia-Pacific Multicancer Screening Market - Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.

As of 2022, the Asia-Pacific multicancer screening market was valued at $0.27 billion and is expected to attain a value of $1.40 billion by 2032. The rising incidence of cancer and growing use of liquid biopsy testing are anticipated to fuel market expansion for multicancer screening in Asia-Pacific.

The market for multicancer screening in Asia-Pacific (APAC) is expected to develop significantly as the area concentrates on improving healthcare infrastructure and tackling the increased incidence of different malignancies. The practice of multicancer screening, which is the simultaneous detection of numerous cancer types by sophisticated diagnostic techniques, is becoming more and more popular throughout Asia-Pacific as people become more aware of the critical role that early detection plays in enhancing treatment outcomes.

The market is being pushed by increasing initiatives for cancer prevention and control, an aging population, and technical breakthroughs in screening technologies. The multicancer screening market is growing as a result of governments and healthcare organizations in the Asia-Pacific area placing a strong emphasis on the adoption of comprehensive cancer screening programs. The market for APAC multicancer screening is expected to grow as demand increases for more accessible and precise cancer diagnosis.

Market Segmentation

Segmentation 1: by Country

China
Japan
India
Australia
South Korea
Rest-of-Asia-Pacific

In 2021, China was the leading contributor to the Asia-Pacific multicancer screening market, with a market share of 32.64%. Japan is the second-largest contributor to the Asia-Pacific multicancer screening market.

Key Market Players and Competition Synopsis

Some of the prominent names established in this market are:

Burning Rock DX
Genecast Biotechnology Co., Ltd
Konica Minolta, Inc. (Ambry Genetics.)

Key Questions Answered in the Report

How is the multicancer screening market revolutionizing cancer detection, treatment, and other applications landscapes?
What are the major market drivers, challenges, and opportunities in the Asia-Pacific multicancer screening market?
What are the key development strategies that are being implemented by major players to sustain themselves in the competitive market?
What will be the growth rate of the Asia-Pacific multicancer screening market during the forecast period?
Who are the leading players with significant offerings in the multicancer screening market?

Key Topics Covered:

1. Markets
1.1 Product Definition
1.2 Inclusion and Exclusion Criteria
1.3 Market Scope
1.4 Research Methodology

2. Market Overview
2.1 Market Overview
2.2 Multicancer Screening Workflow Analysis
2.3 Market Footprint and Growth Potential
2.4 Future Potential
2.5 COVID-19 Impact on the Market

3. Industry Insights
3.1 Patent Analysis
3.2 Reimbursement Scenario
3.3 Supply Chain Analysis
3.4 Pricing Analysis (by Test Type)

4. Market Dynamics
4.1 Overview
4.2 Impact Analysis
4.3 Market Drivers
4.3.1 Early Detection of Cancer Leads to Higher Survival Chances and Better Treatment
4.3.2 Increasing Popularity of Liquid Biopsy Leading to Easier Screening
4.3.3 Reduced Treatment Cost Due to Earlier Cancer Detection
4.4 Market Challenges
4.4.1 Lack of Awareness about the Multicancer Screening Tests
4.4.2 Too Costly to be Used as Preventive Care
4.5 Market Opportunities
4.5.1 Robust Pipeline of Multicancer Screening Tests Poised to Revolutionize Cancer Diagnosis
4.5.2 New Biomarkers being Discovered Regularly

5. Competitive Landscape
5.1 Key Strategies and Developments
5.2 Market Share Analysis (2022)
5.3 Growth-Share Analysis (2022)

6. Asia-Pacific

7. Markets - Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/434cvo

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets